Market Snapshot
| Study Period: | 2017-2025 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 9.1 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The transfection technologies market will show a rapid growth due to the rising incidences of cancer and the increase in research & development in the field of cell based therapies.
As there is increasing prevalence of cancer and growing number of the obese population, there is a rising demand for transfection. This factor is driving the transfection technologies market. In addition, initiatives taken by various government organizations further accentuates the growth of this market. However, the high cost of instruments may restrain the overall market growth in the years to come.
Scope of the report
As per the scope of the report, transfection is an analytical method to study the function of genes and genes products in the cells. Transfection technology is used to introduce nucleic acids like RNA or DNA into cells. It helps to regulate gene therapy, protein metabolism, and mutation of cancer cells by affecting the nuclear genes.
| By Method | |
| Reagent-based Method | |
| Instrument-based Method | |
| Others |
| By Application | |
| Biomedical Research | |
| Therapeutic Delivery | |
| Protein Production |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Reagent-based Method is Showing Significant Growth in the Transfection Technologies Market
Reagent based transfection technology market is experiencing significant growth owing to cost effectiveness and less complicated methods involved during transfection. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection. Instrument-based methods are also less time consuming and accurate and all these advantages drives the growth of this segment.
To understand key trends, Download Sample Report
North America is Found Leading the Transfection Technologies Market
North America is found dominating the market, that is driven by factors such as increasing cases of infectious diseases demanding the need of antibiotics and the growing use of cell-based products which require transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases. The United States and Canada are the major consumers of transfection technologies in this region.
Asia Pacific is also estimated to grow at the highest CAGR, as the developing countries like India and China are the major consumers of transfection technologies in this region.
To understand geography trends, Download Sample Report
Competitive Landscape
The global transfection technologies market is concentrated with international and regional companies that offer products for different types of transfection methods for pharmaceutical and biotechnology companies, contract research organizations (CRO), and academic and research institutes.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Incidences of Cancer
-
4.2.2 Increase in Research & Development in the Field of Cell Based Therapies
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Transfection Technology Instruments
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Method
-
5.1.1 Reagent-based Method
-
5.1.2 Instrument-based Method
-
5.1.3 Others
-
-
5.2 By Application
-
5.2.1 Biomedical Research
-
5.2.2 Therapeutic Delivery
-
5.2.3 Protein Production
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Lonza Group
-
6.1.2 Bio-Rad Laboratories, Inc.
-
6.1.3 Thermo Fisher Scientific
-
6.1.4 Qiagen NV
-
6.1.5 Promega Corporation
-
6.1.6 SignaGen Laboratories
-
6.1.7 Merck KGaA
-
6.1.8 Altogen Biosystems
-
6.1.9 Polyplus-transfection SA
-
6.1.10 Mirus Bio
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Transfection Technologies Market market is studied from 2017 - 2025.
What is the growth rate of Transfection Technologies Market?
The Transfection Technologies Market is growing at a CAGR of 9.1% over the next 5 years.
Which region has highest growth rate in Transfection Technologies Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Transfection Technologies Market?
North America holds highest share in 2019.
Who are the key players in Transfection Technologies Market?
Lonza Group , Bio-Rad Laboratories, Inc. , Promega Corporation , Thermo Fisher Scientific , Qiagen are the major companies operating in Transfection Technologies Market.
